Advertisement

Topics

Bioamber Company Profile

22:11 EDT 25th September 2017 | BioPortfolio

Bioamber is a white biotechnology company dedicated to the development and commercialization of bio-based succinic acid. Bioamber's mission is to license turn-key technology packages to companies seeking to produce succinic acid and its derivatives from renewable feedstocks. Bioamber is a joint venture between DNP Green Technology and Agro-Industrie Recherches et Développements.


News Articles [15 Associated News Articles listed on BioPortfolio]

BioAmber Announces Webcast of Fiscal Second Quarter 2017 Financial Results

MONTREAL, Aug. 1, 2017 /PRNewswire/ - BioAmber Inc. (NYSE:BIOA) today announced that it will report financial results for the second quarter 2017 on Thursday, August 3, 2017 b...

BioAmber Launches a Pharmaceutical Grade for its Bio-succinic Acid

MONTREAL, June 15, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) (TSX: BIOA) is pleased to announce the launch of BIO-SA™ pharmaceutical grade. This new grade of material provides a USP/NF and FCC ...

BioAmber Receives Notice Of Non-Compliance From The NYSE

  Life Sciences Jobs   ...

BioAmber Announces Underwritten Offering Of Common Stock And Warrants

  Life Sciences Jobs   ...

BioAmber Announces US$11 Million Underwritten Offering Of Common Stock And Warrants

  Life Sciences Jobs   ...

BioAmber Announces Record Revenues For The Second Quarter 2017 And Purchase Of Equity Stake In

  Life Sciences Jobs   ...

BioAmber Announces New Chief Executive Officer

MONTREAL, Sept. 14, 2017 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA) (TSX: BIOA) The Board of Directors of BioAmber Inc. is pleased to announce the appointment of Richard P. Eno as its new Chie...

BioAmber Inc. Receives Notice of Non-Compliance from the NYSE

MONTREAL, Sept. 13, 2017 /PRNewswire/ - BioAmber Inc.  (NYSE: BIOA, TSX: BIOA) announced today that the New York Stock Exchange (NYSE) has notified the Company that it is no longer in compliance ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Bioamber

Bioamber is a white biotechnology company dedicated to the development and commercialization of bio-based succinic acid. Bioamber's mission is to license turn-key technology packages to companies ...

More Information about "Bioamber" on BioPortfolio

We have published hundreds of Bioamber news stories on BioPortfolio along with dozens of Bioamber Clinical Trials and PubMed Articles about Bioamber for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bioamber Companies in our database. You can also find out about relevant Bioamber Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record